STUART NANCY (Chief Operating Officer) sold 4.7% of their position (13.20K shares) of CONCERT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $110.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/31/2023ACC: 0001209191-23-005622
Officer· Chief Operating Officer
Since Jul 2018
-13.20K
Net shares
Net seller
$110.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−13.20K
Price / share
$8.35
Trade value
$110.22K
% of position
4.7%
1/30/2023
281.84K→268.64K
Total
Net shares
−13.20K
Net value
-$110.22K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/30/2023 | S · Sale | −13.20K | $8.35 | $110.22K | 4.7% | 281.84K | 268.64K |
| Total | −13.20K | -$110.22K | ||||||
Derivative Transactions0
No derivative transactions reported